Is temporal artery biopsy a worthwhile procedure?

ANZ Journal of Surgery

Volumn 75, Issue 6, 2005, Pages 388-391

  Chong, Elaine W T ^a,b   Robertson, Amanda J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Giant cell arteritis; Temporal arteritis; Temporal artery; Temporal artery biopsy

Indexed keywords

PREDNISOLONE; STEROID;

ARTICLE; FOLLOW UP; GIANT CELL ARTERITIS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; STEROID THERAPY; TEMPORAL ARTERY; VASCULITIS;

BIOPSY; HUMANS; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 21244484659     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2005.03399.x     Document Type: Article

References (36)

1. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology 2003; 42: 413-21.
2. Nordborg E, Nordborg C, Malmvall BE, Anderson R, Bengtsson BA. Giant cell arteritis. Rheum. Dis. Clin. North Am. 1995; 21: 1013-26.
3. Hunder GG. Clinical Manifestations and Diagnoses of Giant Cell (Temporal) Arteritis. Up to date online 11.2, 2003.
4. Evans JM, Bowles C, Bjornsson J et al. Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases. Arthritis Rheum. 1994; 37: 1539.
5. Burke A, Virmani R. Temporal artery biopsy of giant cell arteritis. Pathol. Case Rev. 2001; 6: 265-73.
6. Hall S, Persellin S, Kurland L et al. The therapuetic impact of temporal artery biopsy. Lancet 1983; 2: 1217-20.
7. Hall S, Hunder GC. Is temporal artery biopsy prudent? Mayo Clin. Proc. 1984; 59: 793-6.
8. Bhatti MT, Tabandeh H. Giant cell arteritis: diagnosis and management. Curr. Opin. Ophthalmol. 2001; 12: 393-9.
9. Egge K, Mitbo A, Westby R. Arteritis temporalis. Acta Ophthalmol. 1966; 14: 49-56.
10. Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester Minnesota, 1951 to 1967. Mayo Clin. Proc. 1971; 46: 567-602.
11. Roth AM, Milsow L, Keltner JL. The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch. Ophthalmol. 1984; 102: 901-3.
12. Salvarani C, Macchioni P, Zizzi F et al. Epidemiological and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum. 1991; 34: 351-6.
13. Poller DN, van Wyk Q, Jeffrey MJ. The importance of skip lesions in temporal arteritis. J. Clin. Pathol. 2000; 53: 137-9.
14. Solomon S, Cappa KG. The headache of temporal arteritis. J. Am. Geriatr. Soc. 1987; 35: 163-5.
15. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002; 287: 92-101.
16. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am. J. Ophthalmol. 1999; 128: 211-15.
17. Danesh-Meyer HV, Savino PJ, Eagle RC Jr et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J. Neuroophthalmol. 2000; 20: 213-15.
18. Pless M, Rizzo JF, Lamkin JC et al. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J. Neuroophthalmol. 2000; 20: 216-18.
19. Miller NR. Giant cell arteritis. J. Neuroophthalmol. 2000; 20: 219-20.
20. McDonnell PJ, Moore GW, Miller NR et al. Temporal arteritis. A clinicopathologic study. Ophthalmology 1986; 93: 518-30.
21. Lenton J, Nash R. What is the influence of a temporal artery biopsy on the manasement of temporal arteritis? Br. J. Surg. 2003; 90: 69.
22. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33: 1122-8.
23. Gabriel SE, O'Failon WM, Achkar A et al. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J. Rheumatol. 1995; 22: 93.
24. Miller NR. Visual manifestations of temporal arteritis. Rheum. Dis. Clin. North Am. 2001; 27: 781-97.
25. Birkhead NC, Wagener HP, Shick RM. Treatment of temporal arteritis with adrenal corticisteroids: results in fifty-five cases in which lesion was proved at biopsy. JAMA 1957; 103: 821-7.
26. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment. Arthritis Rheum. 1998; 41: 1497-504.
27. Achkar AA, Lie JT, Hunder GG et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann. Intern. Med. 1994; 120: 987-92.
28. Duhaut P, Pinede L, Bornet H et al. Biopsy-proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of disease. Ann. Rheum. Dis. 1999; 58: 335-41.
29. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in the northwestern area of Spain: study of 57 biopsy proven patients. J. Rheumatol. 1992; 19: 277-80.
30. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in Northwestern Spain, 1988-1997: clinical and epidemiological aspects. Medicine (Baltimore) 1999; 78: 292-308.
31. Wilke WS, Hoffman GS. Treatment of corticosteroid-resistant giant cell arteritis. Rheum. Dis. Clin. North Am. 1995; 21: 59-71.
32. Turbin RE, Kupersmith MJ. Giant cell arteritis. Curr. Treat Options Neurol. 1999; 1: 49-56.
33. Pearce G, Ryan PFJ, Delmas PD et al. The deleterious effects of low-dose corticosteriods on bone density in patients in polymyalgia rheumatica. Br. J. Rheumatol. 1998; 37: 292-9.
34. Ferraccioli GF, Di Poi E, Damato R. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis: state of the art and perspectives. Clin. Exp. Rheumatol. 2000; 18: S58-60.
35. Hoffman GS, Cid MC, Hellmann DB et al. A multicenter, randomised, double-blind, placebo-controlled trial of adjuvant methotrexate treatment of giant cell arteritis. Arthritis Rheum. 2002; 46: 1309-18.
36. Jover JA, Hernandez-Garcia C, Morado IC et al. Combined treatment of giant-cell arteritis with methotrexate and prednisolone: a randomised, double-blind, placebo-controlled trial. Ann. Intern. Med. 2001; 134: 106-14.